Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

MYMD MyMD Pharmaceuticals Inc

1,82

0,00 (0,00%)

14 Feb 2025 - Geschlossen

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

MyMD Pharmaceuticals (NASDAQ:MYMD)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more MyMD Pharmaceuticals Charts.

MyMD Pharmaceuticals (NASDAQ:MYMD)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more MyMD Pharmaceuticals Charts.

News MyMD Pharmaceuticals Inc

TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
Mittwoch 24 Juli 2024 (7 Monate vor) • Business Wire

MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.
Montag 22 Juli 2024 (7 Monate vor) • Business Wire

Form 8-K - Current report
Montag 17 Juni 2024 (8 Monate vor) • Edgar (US Regulatory)

MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
Montag 17 Juni 2024 (8 Monate vor) • Business Wire

Form D - Notice of Exempt Offering of Securities
Freitag 31 Mai 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 23 Mai 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 21 Mai 2024 (9 Monate vor) • Edgar (US Regulatory)

MyMD Pharmaceuticals Secures Strategic Investments
Dienstag 21 Mai 2024 (9 Monate vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 März 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 März 2024 (11 Monate vor) • Edgar (US Regulatory)

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Dienstag 5 März 2024 (11 Monate vor) • Business Wire

Weitere MyMD Pharmaceuticals Inc News-Artikel

Euro vs US Dollar

Invesco QQQ Trust Series 1

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen